City
Epaper

Haryana health minister Vij gets trial dose of Covid vaccine

By IANS | Updated: November 20, 2020 16:29 IST

Chandigarh, Nov 20 Haryana Health Minister Anil Vij was administered a trial dose of India-made coronavirus vaccine Covaxin on ...

Open in App

Chandigarh, Nov 20 Haryana Health Minister Anil Vij was administered a trial dose of India-made coronavirus vaccine Covaxin on Friday.

He was among the first volunteers for the third phase trial of the vaccine.

The 67-year-old BJP leader was administered the dose at the Civil Hospital in Ambala.

He is the first Cabinet minister of any state government who has volunteered to take the trial dose.

Civil Surgeon Kuldeep Singh said the Covaxin dose was administered to Vij.

Before administering the dose, Vij underwent some tests at the hospital.

The minister told the media the vaccine likely to be available to the people by the beginning of next year.

( With inputs from IANS )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalUS seeks private sector push to rival China abroad

EntertainmentAkshay Kumar recalls struggling days outside Subhash Ghai's office with Parmeet Sethi

Politics"Only stated that she hasn't given her rightful place in family": EPS on row over his remarks targeting Kanimozhi

NationalTelangana: Woman accused of posting offensive content on social media, FIR registered

InternationalDelaware eyes India as key partner for economic growth, says Governor Matt Meyer (IANS interview)

Health Realted Stories

Health2,527 eateries inspected, 703 kg of food destroyed as Gujarat steps up paneer–analogue checks

HealthJayant Patil urges Maha govt to scrap DPT vaccine strain sale​

HealthHealth Tips: How to Increase Hemoglobin Levels With Simple Food Pairings

HealthAssam Rifles seizes smuggled haul of rare medicinal plant in Mizoram, apprehends three

HealthPakistan's current response to TB insufficient as cases continue to rise: Report